| 4001 | AREG levels | GCST90468347 | 0.87 |
| 4002 | CRELD2 levels | GCST90468859 | 0.87 |
| 4003 | aparc-a2009s lh volume G-cingul-Post-ventral | GCST90002934 | 0.87 |
| 4004 | Posterior thigh muscle fat infiltration percentage | GCST90267355 | 0.87 |
| 4005 | Transient global amnesia | FING00001374 | 0.86 |
| 4006 | Prevotella sp000434975 abundance in stool | GCST90032518 | 0.86 |
| 4007 | Alpha angle | GCST90129635 | 0.86 |
| 4008 | Osteitis deformans and osteopathies associated with other disorders classified elsewhere (PheCode 731) | GCST90476246 | 0.86 |
| 4009 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T280 | ECGU000280 | 0.86 |
| 4010 | F-caffeinated/sweet liking (derived food-liking factor) | GCST90094720 | 0.86 |
| 4011 | ALPP/MSLN ratio | GCST90313250 | 0.86 |
| 4012 | aparc-a2009s rh area G-pariet-inf-Angular | GCST90003395 | 0.86 |
| 4013 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 10) | GCST90320829 | 0.86 |
| 4014 | SHBG levels | UKBB00000767 | 0.86 |
| 4015 | IDP T1 FAST ROIs L cerebellum VI | GCST90002566 | 0.86 |
| 4016 | Triglyceride (52:5) levels | GCST90488320 | 0.86 |
| 4017 | aparc-a2009s lh area S-temporal-sup | GCST90003369 | 0.86 |
| 4018 | BA-exvivo rh thickness V2 | GCST90003537 | 0.86 |
| 4019 | Mean volume of bilateral amygdala | GCST90474899 | 0.86 |
| 4020 | aparc-a2009s lh area S-calcarine | GCST90003340 | 0.86 |
| 4021 | PDGFC/TFPI ratio | GCST90315636 | 0.85 |
| 4022 | DTI TBSS MD External capsule R | GCST90384604 | 0.85 |
| 4023 | CASP1 levels | GCST90468543 | 0.85 |
| 4024 | FOLR1 levels | GCST90469259 | 0.85 |
| 4025 | PDCD5 levels | GCST90470182 | 0.85 |
| 4026 | APP/DAG1 ratio | GCST90313320 | 0.85 |
| 4027 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T6 | ECGA000006 | 0.85 |
| 4028 | Ganglion cell inner plexiform layer (GCIPL) thickness | GCST90014267 | 0.85 |
| 4029 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T173 | ECGU000173 | 0.85 |
| 4030 | IDP dMRI TBSS L3 Body of corpus callosum | GCST90004174 | 0.85 |
| 4031 | BCHE levels | GCST90468429 | 0.85 |
| 4032 | MFAP4 levels | GCST90469898 | 0.85 |
| 4033 | Family history of certain disabilities and chronic diseases leading to disablement | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000236 | 0.85 |
| 4034 | IDP dMRI TBSS ICVF Pontine crossing tract | GCST90004328 | 0.85 |
| 4035 | KLK11/KLK8 ratio | GCST90315254 | 0.85 |
| 4036 | FSHB levels | GCST90469270 | 0.85 |
| 4037 | CA6 levels | GCST90468515 | 0.85 |
| 4038 | Lysophosphatidylcholine (26:0) [sn1] levels | GCST90025427 | 0.85 |
| 4039 | Treatment/medication code - lansoprazole | Medications | UKBB00000848 | 0.84 |
| 4040 | Volume of right cortical nucleus | GCST90475030 | 0.84 |
| 4041 | CNTN3 levels | GCST90468805 | 0.84 |
| 4042 | ENAH levels | GCST90469106 | 0.84 |
| 4043 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 0.84 |
| 4044 | Suppurative and unspecified otitis media | FING00001346 | 0.84 |
| 4045 | ThalamNuclei lh volume CeM | GCST90002725 | 0.84 |
| 4046 | CXCL5/MESD ratio | GCST90314350 | 0.84 |
| 4047 | IGF2R/RNASET2 ratio | GCST90315132 | 0.84 |
| 4048 | FAM171B levels | GCST90090339 | 0.84 |
| 4049 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T9 | ECGA000009 | 0.84 |
| 4050 | BOLA2 or BOLA2B levels | GCST90468460 | 0.83 |
| 4051 | ICD10 N91.0, N91.1, N91.2: Amenorrhea, including primary amenorrhea, secondary amenorrhea and unspecified amenorrhea | GCST90454219 | 0.83 |
| 4052 | Medication use (HMG CoA reductase inhibitors) | GCST90018769 | 0.83 |
| 4053 | IDP dMRI ProbtrackX ICVF ptr l | GCST90004394 | 0.83 |
| 4054 | Blood clot / pulmonary embolism / deep vein thrombosis (DVT) | GCST90475209 | 0.83 |
| 4055 | IDP dMRI TBSS ICVF Posterior thalamic radiation R | GCST90004355 | 0.83 |
| 4056 | Number of self-reported non-cancer illnesses | Medical conditions | UKBB00000541 | 0.83 |
| 4057 | Nonalcoholic fatty liver disease in overweight individuals (25<=BMI<=30) | GCST90275047 | 0.83 |
| 4058 | PLA2G1B levels | GCST90470246 | 0.83 |
| 4059 | CD22/FCRL1 ratio | GCST90313757 | 0.83 |
| 4060 | APRT/EREG ratio | GCST90313335 | 0.83 |
| 4061 | HGF/PLAUR ratio | GCST90315059 | 0.83 |
| 4062 | DDAH1 levels | GCST90468966 | 0.83 |
| 4063 | TPK1 levels | GCST90470943 | 0.83 |
| 4064 | MEGF9/OXT ratio | GCST90315419 | 0.83 |
| 4065 | Left-hemisphere somatomotor network to left-hemisphere default mode network white-matter structural connectivity | GCST90302674 | 0.83 |
| 4066 | T1 FreeSurfer DKT rh lingual area | GCST90384297 | 0.83 |
| 4067 | Polyp of the female genital tract | FING00001190 | 0.83 |
| 4068 | Fracture of rib(s), sternum and thoracic spine | FING00000558 | 0.83 |
| 4069 | ICD10 C53: Malignant neoplasm of cervix uteri | GCST90454202 | 0.83 |
| 4070 | CELA2A levels | GCST90468701 | 0.82 |
| 4071 | IDP dMRI ProbtrackX ICVF slf l | GCST90004396 | 0.82 |
| 4072 | Coffee difference liking | GCST90094738 | 0.82 |
| 4073 | Coagulation defects (PheCode 286) | GCST90475796 | 0.82 |
| 4074 | CRADD/EDAR ratio | GCST90314235 | 0.82 |
| 4075 | aseg rh volume Cerebellum-Cortex | GCST90002636 | 0.82 |
| 4076 | Longitudinal peak diastolic strain rate | GCST90019013 | 0.82 |
| 4077 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T158 | ECGU000158 | 0.82 |
| 4078 | Left ventricular ejection fraction | GCST90268125 | 0.82 |
| 4079 | IDP dMRI TBSS FA Cerebral peduncle R | GCST90003891 | 0.82 |
| 4080 | JAM2/THBD ratio | GCST90315239 | 0.82 |
| 4081 | aparc-a2009s lh area G-pariet-inf-Supramar | GCST90003322 | 0.82 |
| 4082 | CDC27 levels | GCST90468664 | 0.82 |
| 4083 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T171 | ECGU000171 | 0.82 |
| 4084 | Osteoporosis (PheCode 743.1) | GCST90476384 | 0.82 |
| 4085 | IL6ST/PDGFRA ratio | GCST90315169 | 0.82 |
| 4086 | Non-cancer illness code, self-reported - depression | Medical conditions | UKBB00000507 | 0.82 |
| 4087 | T1 FreeSurfer aseg Right-choroid-plexus | GCST90384170 | 0.81 |
| 4088 | ATXN10/CASP10 ratio | GCST90313396 | 0.81 |
| 4089 | Omega-3 fatty acids to total fatty acids percentage | GCST90502450 | 0.81 |
| 4090 | Calculus of kidney and ureter | FING00000236 | 0.81 |
| 4091 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T98 | ECGA000098 | 0.81 |
| 4092 | Dysmenorrheic pain severity | GCST006656 | 0.81 |
| 4093 | Volume of right basal nucleus | GCST90475015 | 0.81 |
| 4094 | Excessive sweating | GCST006090 | 0.81 |
| 4095 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T119 | ECGA000119 | 0.81 |
| 4096 | SLC27A4/TDRKH ratio | GCST90315851 | 0.81 |
| 4097 | Takes medication for congestive heart failure? | GCST90475201 | 0.81 |
| 4098 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T172 | ECGU000172 | 0.81 |
| 4099 | Indolebutyrate levels | GCST90199759 | 0.81 |
| 4100 | Asphyxia and hypoxemia (PheCode 1013) | GCST90475559 | 0.81 |
| 4101 | Pustulosis palmaris et plantaris | FING00001233 | 0.81 |
| 4102 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T8 | ECGA000008 | 0.81 |
| 4103 | HSPG2/VASN ratio | GCST90315094 | 0.81 |
| 4104 | Enthesopathies of lower limb, excluding foot | FING00000509 | 0.81 |
| 4105 | aparc-a2009s rh volume G-pariet-inf-Supramar | GCST90003024 | 0.81 |
| 4106 | Oily fish intake | Diet | UKBB00000547 | 0.81 |
| 4107 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T457 | ECGA000457 | 0.80 |
| 4108 | PECAM1 levels | GCST90470206 | 0.80 |
| 4109 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T354 | ECGA000354 | 0.80 |
| 4110 | IL31RA levels | GCST90469589 | 0.80 |
| 4111 | HippSubfield lh volume molecular-layer-HP-head | GCST90002677 | 0.80 |
| 4112 | IDP T1 FIRST left putamen volume | GCST90002440 | 0.80 |
| 4113 | SOST/SPP1 ratio | GCST90315871 | 0.80 |
| 4114 | DOK2 levels | GCST90469029 | 0.80 |
| 4115 | Osteoporosis | GCST90468145 | 0.80 |
| 4116 | FABP5 levels | GCST90469177 | 0.80 |
| 4117 | Dorsopathies | FING00000473 | 0.80 |
| 4118 | DTI TBSS L3 Splenium of corpus callosum | GCST90384528 | 0.80 |
| 4119 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T358 | ECGA000358 | 0.80 |
| 4120 | DTI TBSS FA Posterior corona radiata R | GCST90384406 | 0.79 |
| 4121 | aparc-a2009s rh area G-oc-temp-lat-fusifor | GCST90003391 | 0.79 |
| 4122 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T363 | ECGA000363 | 0.79 |
| 4123 | Nasal polyps (PheCode 471) | GCST90476019 | 0.79 |
| 4124 | DECR1/MAP2K6 ratio | GCST90314447 | 0.79 |
| 4125 | eGFR in diabetes mellitus (loose) kidney healthy controls (minimal adjustment) | GCST90624778 | 0.79 |
| 4126 | DPP4/ITGB1 ratio | GCST90314540 | 0.79 |
| 4127 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320672 | 0.79 |
| 4128 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T177 | ECGU000177 | 0.79 |
| 4129 | FOXO3/MAP3K5 ratio | GCST90314880 | 0.79 |
| 4130 | NTRK2 levels | GCST90470097 | 0.78 |
| 4131 | L1CAM levels | GCST90469723 | 0.78 |
| 4132 | wg rh intensity-contrast entorhinal | GCST90003832 | 0.78 |
| 4133 | MMP10 levels | GCST90469915 | 0.78 |
| 4134 | RBP5 levels | GCST90470439 | 0.78 |
| 4135 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 117) | GCST90320680 | 0.78 |
| 4136 | Placental weight (fetal genotype, adjusted for sex and gestational age) | GCST90275189 | 0.78 |
| 4137 | DNAJC6 levels | GCST90469017 | 0.78 |
| 4138 | Pulmonary fibrosis | GCST90018688 | 0.78 |
| 4139 | Principal component-derived dietary pattern 33 | GCST90133038 | 0.78 |
| 4140 | IL6 expression at 6 weeks in whole blood upon Bbmix moi30 stimulation in Lyme borreliosis | GCST90275789 | 0.78 |
| 4141 | Other disorders of testis (PheCode 603) | GCST90476156 | 0.78 |
| 4142 | DBN1 levels | GCST90468950 | 0.78 |
| 4143 | Osteoarthritis | GCST90134288 | 0.78 |
| 4144 | DKK1/PDGFA ratio | GCST90314475 | 0.78 |
| 4145 | ANG levels | GCST90468307 | 0.77 |
| 4146 | Shoulder lesions | Other soft tissue disorders | UKBB00000769 | 0.77 |
| 4147 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T61 | ECGA000061 | 0.77 |
| 4148 | LAT/LYN ratio | GCST90315283 | 0.77 |
| 4149 | Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302761 | 0.77 |
| 4150 | Diseases of arteries, arterioles and capillaries (FINNGEN) | FING00000423 | 0.77 |
| 4151 | IDP dMRI TBSS ICVF Sagittal stratum L | GCST90004358 | 0.77 |
| 4152 | OSMR levels | GCST90470132 | 0.77 |
| 4153 | Triacylglycerol_50:2_[M+NH4]1+ levels | GCST90060473 | 0.77 |
| 4154 | BCAN/CD200 ratio | GCST90313477 | 0.77 |
| 4155 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T362 | ECGA000362 | 0.77 |
| 4156 | MTDH levels | GCST90469954 | 0.77 |
| 4157 | Ovarian dysfunction | FING00001133 | 0.76 |
| 4158 | MCAM levels | GCST90469870 | 0.76 |
| 4159 | Principal component-derived dietary pattern 43 | GCST90133048 | 0.76 |
| 4160 | COLEC12 levels | GCST90468824 | 0.76 |
| 4161 | ATG16L1 levels | GCST90468383 | 0.76 |
| 4162 | DNM3 levels | GCST90469022 | 0.76 |
| 4163 | NCR3LG1 levels | GCST90470010 | 0.76 |
| 4164 | Leisure/social activities - Adult education class | Social support | UKBB00000398 | 0.76 |
| 4165 | Medication for pain relief, constipation, heartburn - None of the above | Medication | UKBB00000457 | 0.76 |
| 4166 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T170 | ECGU000170 | 0.76 |
| 4167 | Triacylglycerol_52:3_[M+NH4]1+ levels | GCST90060509 | 0.76 |
| 4168 | DPP6/SEZ6L ratio | GCST90314544 | 0.76 |
| 4169 | HGF/MMP8 ratio | GCST90315055 | 0.76 |
| 4170 | OTUD7B levels | GCST90470137 | 0.76 |
| 4171 | SNX9/VASH1 ratio | GCST90315866 | 0.76 |
| 4172 | Glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) levels | GCST90200105 | 0.76 |
| 4173 | PPP1R12A/TXNDC5 ratio | GCST90315714 | 0.76 |
| 4174 | CD69/EDAR ratio | GCST90313875 | 0.76 |
| 4175 | IDP dMRI TBSS MO Posterior limb of internal capsule R | GCST90003970 | 0.75 |
| 4176 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T423 | ECGU000423 | 0.75 |
| 4177 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108 | ECGU000108 | 0.75 |
| 4178 | Histidine levels | GCST90243404 | 0.75 |
| 4179 | PLXDC1 levels | GCST90470263 | 0.75 |
| 4180 | SEL1L levels | GCST90470564 | 0.75 |
| 4181 | Glycerate levels | GCST90200290 | 0.75 |
| 4182 | Myocardial fractal dimension (slice 4) | GCST90000290 | 0.75 |
| 4183 | APP/NID2 ratio | GCST90313327 | 0.75 |
| 4184 | Right-hemisphere control network to right-hemisphere control network white-matter structural connectivity | GCST90302834 | 0.75 |
| 4185 | UBE2L6 levels | GCST90471001 | 0.75 |
| 4186 | HNRNPK levels | GCST90469469 | 0.75 |
| 4187 | CKAP4/LTBR ratio | GCST90314074 | 0.75 |
| 4188 | low density lipoprotein cholesterol (LDLC, mean, inv-norm transformed) | GCST90475416 | 0.75 |
| 4189 | F3 levels | GCST90012014 | 0.75 |
| 4190 | ADAMTS15 levels | GCST90468223 | 0.75 |
| 4191 | aparc-a2009s rh volume Pole-occipital | GCST90003040 | 0.75 |
| 4192 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T170 | ECGA000170 | 0.75 |
| 4193 | PTPRN2/RTBDN ratio | GCST90315754 | 0.74 |
| 4194 | ANGPT2 levels | GCST90468301 | 0.74 |
| 4195 | wg lh intensity-contrast fusiform | GCST90003798 | 0.74 |
| 4196 | STXBP1 levels | GCST90470777 | 0.74 |
| 4197 | PBXIP1 levels | GCST90470164 | 0.74 |
| 4198 | ITGB1BP2/PTPN6 ratio | GCST90315218 | 0.74 |
| 4199 | Urine taurocholenate sulfate* levels in chronic kidney disease | GCST90266041 | 0.74 |
| 4200 | Bacterial pneumoniae | FING00000139 | 0.74 |
| 4201 | Emotional neglect | GCST90551846 | 0.74 |
| 4202 | Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000429 | 0.74 |
| 4203 | SPOCK1 levels | GCST90470730 | 0.74 |
| 4204 | GIPC2 levels | GCST90469347 | 0.74 |
| 4205 | ECE1 levels | GCST90469061 | 0.74 |
| 4206 | PDGFA/SPARC ratio | GCST90315620 | 0.74 |
| 4207 | Autoimmune polyglandular failure | FING00000135 | 0.74 |
| 4208 | IDP dMRI TBSS FA Sagittal stratum L | GCST90003908 | 0.73 |
| 4209 | rfMRI amplitudes (ICA100 node 45) | GCST90004633 | 0.73 |
| 4210 | IDP dMRI ProbtrackX ICVF str r | GCST90004399 | 0.73 |
| 4211 | Total protein levels | GCST90018756 | 0.73 |
| 4212 | CD300LG/CLEC14A ratio | GCST90313801 | 0.73 |
| 4213 | FABP6 levels | GCST90469178 | 0.73 |
| 4214 | aparc-DKTatlas rh volume supramarginal | GCST90002922 | 0.73 |
| 4215 | Diacylglycerol_36:3_[M+H-H2O]1+ levels | GCST90060189 | 0.73 |
| 4216 | Plasma sulfate of piperine metabolite C18H21NO3 (1)* levels in chronic kidney disease | GCST90266016 | 0.73 |
| 4217 | BIRC2/CD40LG ratio | GCST90313517 | 0.73 |
| 4218 | LAMA4 levels | GCST90469731 | 0.73 |
| 4219 | IDP dMRI TBSS ICVF Superior corona radiata R | GCST90004351 | 0.73 |
| 4220 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 0.73 |
| 4221 | Horseradish liking | GCST90094783 | 0.73 |
| 4222 | EGF/MGLL ratio | GCST90314610 | 0.73 |
| 4223 | BA-exvivo rh volume BA1 | GCST90002849 | 0.72 |
| 4224 | LRP1 levels | GCST90469797 | 0.72 |
| 4225 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T63 | ECGA000063 | 0.72 |
| 4226 | IDP T1 FAST ROIs L temporal pole | GCST90002465 | 0.72 |
| 4227 | DBI/EDAR ratio | GCST90314408 | 0.72 |
| 4228 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T124 | ECGA000124 | 0.72 |
| 4229 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T464 | ECGU000464 | 0.72 |
| 4230 | TNFRSF10A levels | GCST90470899 | 0.72 |
| 4231 | MESD levels | GCST90469891 | 0.72 |
| 4232 | IDP dMRI TBSS L2 Cingulum cingulate gyrus R | GCST90004157 | 0.72 |
| 4233 | Left molecular layer hippocampal volume (body) | GCST90267953 | 0.72 |
| 4234 | Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454) | GCST90269551 | 0.72 |
| 4235 | SPINK1 levels | GCST90470721 | 0.72 |
| 4236 | ThalamNuclei rh volume MDl | GCST90002748 | 0.72 |
| 4237 | COMMD1 levels | GCST90468825 | 0.72 |
| 4238 | IDP dMRI TBSS OD External capsule L | GCST90004435 | 0.71 |
| 4239 | aparc-pial rh area superiorparietal | GCST90003202 | 0.71 |
| 4240 | Uric acid levels | GCST90278646 | 0.71 |
| 4241 | Sphingomyelin_42:2_[M+H]1+ levels | GCST90060403 | 0.71 |
| 4242 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T117 | ECGA000117 | 0.71 |
| 4243 | OGA levels | GCST90470117 | 0.71 |
| 4244 | Free testosterone levels | GCST90239826 | 0.70 |
| 4245 | BA-exvivo rh area BA4p | GCST90003226 | 0.70 |
| 4246 | aparc-a2009s lh area G+S-subcentral | GCST90003300 | 0.70 |
| 4247 | Bicarbonate (minimum, inv-norm transformed) | GCST90475150 | 0.70 |
| 4248 | HSPB6 levels | GCST90469490 | 0.70 |
| 4249 | IDP dMRI TBSS L3 Superior cerebellar peduncle L | GCST90004184 | 0.70 |
| 4250 | Cereal consumption (bowls per week) (UKB data field 1458) | GCST90132982 | 0.70 |
| 4251 | Luteinizing hormone levels | GCST90483478 | 0.70 |
| 4252 | F8 levels | GCST90240725 | 0.70 |
| 4253 | Bursitis (PheCode 726.3) | GCST90476240 | 0.70 |
| 4254 | aparc-Desikan rh area parsopercularis | GCST90003124 | 0.70 |
| 4255 | PDGFB/PRKAR1A ratio | GCST90315624 | 0.70 |
| 4256 | wg lh intensity-contrast middletemporal | GCST90003806 | 0.70 |
| 4257 | BLVRB/CA1 ratio | GCST90313521 | 0.70 |
| 4258 | IDP dMRI ProbtrackX FA slf r | GCST90003947 | 0.70 |
| 4259 | HHIP levels | GCST90617097 | 0.70 |
| 4260 | Early age-related macular degeneration | GCST010723 | 0.70 |
| 4261 | Otosclerosis | FING00001131 | 0.70 |
| 4262 | Wears glasses or contact lenses | Eyesight | UKBB00000907 | 0.70 |
| 4263 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T169 | ECGU000169 | 0.69 |
| 4264 | IDP dMRI TBSS MD Anterior limb of internal capsule R | GCST90004043 | 0.69 |
| 4265 | Nontoxic nodular goiter (PheCode 241) | GCST90475638 | 0.69 |
| 4266 | VSTM2B levels | GCST90471056 | 0.69 |
| 4267 | B4GALT1/SMOC2 ratio | GCST90313433 | 0.69 |
| 4268 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T359 | ECGA000359 | 0.69 |
| 4269 | F3/GFRA1 ratio | GCST90314741 | 0.69 |
| 4270 | aparc-DKTatlas rh area fusiform | GCST90003270 | 0.69 |
| 4271 | BAG3 levels | GCST90468416 | 0.69 |
| 4272 | Omega-3 fatty acids to total fatty acids percentage | GCST90502082 | 0.69 |
| 4273 | aparc-Desikan rh area fusiform | GCST90003113 | 0.69 |
| 4274 | Plasma 3-hydroxybutyroylglycine** levels in chronic kidney disease | GCST90264488 | 0.69 |
| 4275 | MPO levels | GCST90469937 | 0.68 |
| 4276 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T235 | ECGU000235 | 0.68 |
| 4277 | PTPN1 levels | GCST90470376 | 0.68 |
| 4278 | REG4 levels | GCST90470451 | 0.68 |
| 4279 | Status post-ami | FING00001333 | 0.68 |
| 4280 | AKT1S1 levels | GCST90468276 | 0.68 |
| 4281 | Patient classification on admission (recoded) - Day case | Summary Administration | UKBB00000636 | 0.68 |
| 4282 | CACNA2D3 levels | GCST90243348 | 0.68 |
| 4283 | Depression or dysthymia | FING00000400 | 0.68 |
| 4284 | AMIGO2 levels | GCST90468292 | 0.68 |
| 4285 | GTPBP2 levels | GCST90469417 | 0.68 |
| 4286 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T438 | ECGU000438 | 0.68 |
| 4287 | Retinal detachments and defects (PheCode 361) | GCST90475845 | 0.68 |
| 4288 | VEGFD levels | GCST90471037 | 0.68 |
| 4289 | CNPY4/ERBIN ratio | GCST90314148 | 0.68 |
| 4290 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T176 | ECGU000176 | 0.67 |
| 4291 | NFATC1/TJAP1 ratio | GCST90315540 | 0.67 |
| 4292 | ANP32B levels | GCST90240176 | 0.67 |
| 4293 | DTI autoptx MD cgc l tract | GCST90385224 | 0.67 |
| 4294 | TAX1BP1 levels | GCST90470808 | 0.67 |
| 4295 | NCS1 levels | GCST90470011 | 0.67 |
| 4296 | Creatinine levels | GCST90025946 | 0.67 |
| 4297 | DTI TBSS L1 External capsule L | GCST90384461 | 0.67 |
| 4298 | TGFBR2/THBD ratio | GCST90315916 | 0.67 |
| 4299 | CD79B/TNFRSF13B ratio | GCST90313902 | 0.67 |
| 4300 | DTI TBSS MD Cingulum cingulate gyrus R | GCST90384606 | 0.66 |
| 4301 | DTI TBSS L3 Uncinate fasciculus R | GCST90384568 | 0.66 |
| 4302 | IDP T1 FAST ROIs brain stem | GCST90002561 | 0.66 |
| 4303 | HLA-DQA2 levels | GCST90427049 | 0.66 |
| 4304 | CDH15 levels | GCST90468668 | 0.66 |
| 4305 | IGFBP6/MFAP5 ratio | GCST90315135 | 0.66 |
| 4306 | IDP dMRI TBSS L1 Anterior corona radiata L | GCST90004098 | 0.66 |
| 4307 | Cholesteryl ester_14:0_[M+NH4]1+ levels | GCST90060197 | 0.66 |
| 4308 | CXCL16/NOTCH1 ratio | GCST90314339 | 0.66 |
| 4309 | Average weekly beer plus cider intake | Alcohol | UKBB00000082 | 0.66 |
| 4310 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T110 | ECGU000110 | 0.66 |
| 4311 | CCL17/F2R ratio | GCST90313686 | 0.66 |
| 4312 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T168 | ECGU000168 | 0.66 |
| 4313 | Prescriptions - bisoprolol | selective beta1 antagonist,beta blocker | UKBB00000672 | 0.66 |
| 4314 | DAB2/FKBP1B ratio | GCST90314362 | 0.66 |
| 4315 | Premature beats (PheCode 427.6) | GCST90475977 | 0.66 |
| 4316 | Chalazion | FING00000267 | 0.66 |
| 4317 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T360 | ECGA000360 | 0.66 |
| 4318 | aparc-DKTatlas lh volume postcentral | GCST90002882 | 0.65 |
| 4319 | Parental longevity (father's age at death) | GCST006700 | 0.65 |
| 4320 | CHRDL2 levels | GCST90468751 | 0.65 |
| 4321 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T144 | ECGU000144 | 0.65 |
| 4322 | LY6D/PLA2G10 ratio | GCST90315345 | 0.65 |
| 4323 | APPL2 levels | GCST90468343 | 0.65 |
| 4324 | Right-hemisphere limbic network to hippocampus white-matter structural connectivity | GCST90302831 | 0.65 |
| 4325 | DTI autoptx L1 cst r tract | GCST90385148 | 0.65 |
| 4326 | Right-hemisphere visual network to right-hemisphere default mode network white-matter structural connectivity | GCST90302780 | 0.65 |
| 4327 | Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61) | GCST90668505 | 0.65 |
| 4328 | SUMF2 levels | GCST90470784 | 0.65 |
| 4329 | Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARB | UKBB00000690 | 0.65 |
| 4330 | NCR1 levels | GCST90090153 | 0.65 |
| 4331 | Holdemania abundance in stool | GCST90032432 | 0.65 |
| 4332 | THBS2 levels | GCST90470854 | 0.65 |
| 4333 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T361 | ECGA000361 | 0.65 |
| 4334 | MICB or MICA levels | GCST90469905 | 0.65 |
| 4335 | Right-hemisphere somatomotor network to right-hemisphere control network white-matter structural connectivity | GCST90302792 | 0.65 |
| 4336 | DTI TBSS FA Retrolenticular part of internal capsule R | GCST90384400 | 0.65 |
| 4337 | LGALS1 levels | GCST90469759 | 0.65 |
| 4338 | Atrial fibrillation and flutter (PheCode 427.2) | GCST90043977 | 0.65 |
| 4339 | aparc-DKTatlas rh volume lateraloccipital | GCST90002902 | 0.65 |
| 4340 | Coffee type: Instant coffee (UKB data field 1508_2) | GCST90041802 | 0.65 |
| 4341 | CAG-177 abundance in stool | GCST90032261 | 0.65 |
| 4342 | aparc-a2009s rh thickness G-temporal-middle | GCST90003714 | 0.65 |
| 4343 | Bariatric surgery (PheCode 539) | GCST90476055 | 0.64 |
| 4344 | wg rh intensity-contrast precentral | GCST90003850 | 0.64 |
| 4345 | NH4_C22:4 Cholesteryl ester levels in chronic kidney disease | GCST90257227 | 0.64 |
| 4346 | ThalamNuclei rh volume PuI | GCST90002738 | 0.64 |
| 4347 | HAVCR1 levels | GCST90469431 | 0.64 |
| 4348 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 116) | GCST90320935 | 0.64 |
| 4349 | Right-hemisphere somatomotor network to amygdala white-matter structural connectivity | GCST90302799 | 0.64 |
| 4350 | aseg global volume SupraTentorial | GCST90002595 | 0.64 |
| 4351 | PLXNA4/SPRY2 ratio | GCST90315687 | 0.64 |
| 4352 | DAPP1/PMVK ratio | GCST90314396 | 0.64 |
| 4353 | PSTPIP2 levels | GCST90470366 | 0.64 |
| 4354 | NIT2 levels | GCST90470051 | 0.64 |
| 4355 | CTSH levels | GCST90088501 | 0.64 |
| 4356 | HS6ST2 levels | GCST90469480 | 0.64 |
| 4357 | Succinylcarnitine levels | GCST90243874 | 0.64 |
| 4358 | Heart failure and bmi 25plus | FING00000603 | 0.64 |
| 4359 | aparc-Desikan lh area TotalSurface | GCST90003073 | 0.64 |
| 4360 | IDP dMRI ProbtrackX OD fmi | GCST90004461 | 0.64 |
| 4361 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458) | GCST90269555 | 0.63 |
| 4362 | NPTXR levels | GCST90470080 | 0.63 |
| 4363 | KIRREL2 levels | GCST90469690 | 0.63 |
| 4364 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T141 | ECGU000141 | 0.63 |
| 4365 | SPRY2 levels | GCST90470738 | 0.63 |
| 4366 | EDAR/PSRC1 ratio | GCST90314584 | 0.63 |
| 4367 | Smoking status, ever vs never | Other measurement | UKBB00000782 | 0.63 |
| 4368 | Gastritis and duodenitis | Diseases of oesophagus, stomach and duodenum | UKBB00000278 | 0.63 |
| 4369 | Internal derangement of knee | injuries & poisonings | UKBB00000368 | 0.63 |
| 4370 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320655 | 0.63 |
| 4371 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T419 | ECGU000419 | 0.63 |
| 4372 | FCRL3 levels | GCST90469207 | 0.63 |
| 4373 | ALB levels | GCST90278616 | 0.63 |
| 4374 | Total testosterone levels | GCST90012113 | 0.63 |
| 4375 | FOXO3 levels | GCST90469266 | 0.63 |
| 4376 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T15 | ECGA000015 | 0.63 |
| 4377 | Glycosyl ceramide (d18:2/24:1, d18:1/24:2) levels | GCST90200118 | 0.62 |
| 4378 | IDP T1 FAST ROIs R cerebellum crus II | GCST90002574 | 0.62 |
| 4379 | DAG1/DKK1 ratio | GCST90314373 | 0.62 |
| 4380 | CIRBP levels | GCST90468756 | 0.62 |
| 4381 | Oral glucose tolerance test-2h | GCST90566423 | 0.62 |
| 4382 | aparc-Desikan rh volume lateraloccipital | GCST90002811 | 0.62 |
| 4383 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T71 | ECGU000071 | 0.62 |
| 4384 | Brussel sprout liking | GCST90094714 | 0.62 |
| 4385 | IDP dMRI ProbtrackX MD cst r | GCST90004228 | 0.61 |
| 4386 | Leisure/social activities - Other group activity | Social support | UKBB00000400 | 0.61 |
| 4387 | Glomerular filtration rate (cystatin C) | GCST003375 | 0.61 |
| 4388 | DTI autoptx L2 str l tract | GCST90385189 | 0.61 |
| 4389 | IDP dMRI TBSS L3 Genu of corpus callosum | GCST90004173 | 0.61 |
| 4390 | Hyperthyroidism | GCST90468136 | 0.61 |
| 4391 | aparc-a2009s rh area S-subparietal | GCST90003441 | 0.61 |
| 4392 | GNPDA2 levels | GCST90469374 | 0.61 |
| 4393 | COL28A1 levels | GCST90468815 | 0.61 |
| 4394 | Peripheral artery disease | GCST90018670 | 0.61 |
| 4395 | Microalbumin urine | GCST90278639 | 0.61 |
| 4396 | HNRNPK/VASH1 ratio | GCST90315071 | 0.61 |
| 4397 | CDC42BPB levels | GCST90468666 | 0.61 |
| 4398 | ASGR1/DCBLD2 ratio | GCST90313364 | 0.61 |
| 4399 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T364 | ECGA000364 | 0.61 |
| 4400 | Left-hemisphere dorsal attention network to left-hemisphere default mode network white-matter structural connectivity | GCST90302693 | 0.61 |
| 4401 | GUSB levels | GCST90469421 | 0.61 |
| 4402 | IDP dMRI TBSS ICVF Medial lemniscus R | GCST90004335 | 0.61 |
| 4403 | aparc-a2009s lh area S-postcentral | GCST90003363 | 0.61 |
| 4404 | GAST levels | GCST90469307 | 0.60 |
| 4405 | Principal component-derived dietary pattern 11 | GCST90133016 | 0.60 |
| 4406 | DTI autoptx FA atr l tract | GCST90385114 | 0.60 |
| 4407 | Abnormal results of function study of thyro (PheCode 246.7) | GCST90475654 | 0.60 |
| 4408 | DTI TBSS MD Posterior thalamic radiation R | GCST90384600 | 0.60 |
| 4409 | CDSN/WFDC12 ratio | GCST90313999 | 0.60 |
| 4410 | Volume of right cortico-amygdaloid transition area | GCST90474911 | 0.60 |
| 4411 | Pancreas fat | GCST90016675 | 0.60 |
| 4412 | GGH/INHBC ratio | GCST90314928 | 0.60 |
| 4413 | PCDHB15 levels | GCST90470173 | 0.60 |
| 4414 | EDAR/TXNDC5 ratio | GCST90314593 | 0.60 |
| 4415 | LYN/SIRT2 ratio | GCST90315349 | 0.60 |
| 4416 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320627 | 0.60 |
| 4417 | IDP dMRI ProbtrackX ISOVF atr l | GCST90004527 | 0.60 |
| 4418 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T128 | ECGU000128 | 0.60 |
| 4419 | IDP dMRI TBSS FA Posterior limb of internal capsule L | GCST90003896 | 0.60 |
| 4420 | MPHOSPH8 levels | GCST90469934 | 0.60 |
| 4421 | APP/VEGFC ratio | GCST90313333 | 0.60 |
| 4422 | DPEP1 levels | GCST90090302 | 0.60 |
| 4423 | Volume of right lateral nucleus | GCST90475034 | 0.60 |
| 4424 | DAB2/FKBP5 ratio | GCST90314363 | 0.59 |
| 4425 | CTSV levels | GCST90468917 | 0.59 |
| 4426 | total creatine kinase (minimum, inv-norm transformed) | GCST90476416 | 0.59 |
| 4427 | DTI TBSS MD Retrolenticular part of internal capsule L | GCST90384593 | 0.59 |
| 4428 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T416 | ECGU000416 | 0.59 |
| 4429 | Sphingomyelin (d18:2/23:0, d18:1/23:1, d17:1/24:1) levels | GCST90200033 | 0.59 |
| 4430 | ECM1 levels | GCST90469065 | 0.59 |
| 4431 | eGFR in diabetes mellitus (loose) (minimal adjustment) | GCST90624783 | 0.59 |
| 4432 | Creatinine levels | GCST90497236 | 0.59 |
| 4433 | DFFA levels | GCST90468987 | 0.59 |
| 4434 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T365 | ECGA000365 | 0.59 |
| 4435 | IDP dMRI ProbtrackX ICVF ifo r | GCST90004388 | 0.59 |
| 4436 | aseg global volume BrainSeg | GCST90002590 | 0.59 |
| 4437 | DNAJB14 levels | GCST90240952 | 0.59 |
| 4438 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T69 | ECGU000069 | 0.59 |
| 4439 | IDP dMRI TBSS L2 Posterior corona radiata L | GCST90004150 | 0.59 |
| 4440 | NTN1 levels | GCST90242047 | 0.59 |
| 4441 | CBLIF levels | GCST90468552 | 0.59 |
| 4442 | KLK8 levels | GCST90422316 | 0.59 |
| 4443 | DTI TBSS L2 External capsule R | GCST90384508 | 0.59 |
| 4444 | Duodenal ulcer | GCST90270928 | 0.59 |
| 4445 | Suicide or other Intentional self-harm | FING00001345 | 0.59 |
| 4446 | FIS1/PDGFB ratio | GCST90314830 | 0.58 |
| 4447 | Operation code - bilateral oophorectomy | Operations | UKBB00000550 | 0.58 |
| 4448 | NPDC1/TAFA5 ratio | GCST90315550 | 0.58 |
| 4449 | IDP dMRI TBSS L1 Inferior cerebellar peduncle L | GCST90004086 | 0.58 |
| 4450 | CTF1/ITGB1BP2 ratio | GCST90314305 | 0.58 |
| 4451 | HMOX2 levels | GCST90469466 | 0.58 |
| 4452 | BLOC1S3 levels | GCST90468450 | 0.58 |
| 4453 | CXCL5/PPIB ratio | GCST90314352 | 0.58 |
| 4454 | TNN levels | GCST90470927 | 0.58 |
| 4455 | Hypertensive Heart Disease | FING00000639 | 0.58 |
| 4456 | Gout (PheCode 274.1) | GCST90476379 | 0.58 |
| 4457 | CD200 levels | GCST90468606 | 0.58 |
| 4458 | Alcohol use and misuse (confirmatory factor analysis Factor 22) | GCST90309356 | 0.58 |
| 4459 | EDAR/ENO2 ratio | GCST90314574 | 0.58 |
| 4460 | CLEC14A levels | GCST90468766 | 0.58 |
| 4461 | IDP dMRI ProbtrackX L2 ptr r | GCST90004293 | 0.57 |
| 4462 | DBNL/EDAR ratio | GCST90314416 | 0.57 |
| 4463 | NECTIN2/NPDC1 ratio | GCST90315528 | 0.57 |
| 4464 | Asthma | respiratory | UKBB00000054 | 0.57 |
| 4465 | Membranous nephropathy | GCST010006 | 0.57 |
| 4466 | 5-oxoproline levels | GCST90243437 | 0.57 |
| 4467 | DYNLL1 levels | GCST90240984 | 0.57 |
| 4468 | S100A11 levels | GCST90470512 | 0.57 |
| 4469 | SH3GLB2 levels | GCST90470621 | 0.57 |
| 4470 | wg lh intensity-contrast precuneus | GCST90003816 | 0.57 |
| 4471 | IDP dMRI TBSS ICVF Splenium of corpus callosum | GCST90004331 | 0.57 |
| 4472 | KCTD5 levels | GCST90469670 | 0.57 |
| 4473 | ITGB1BP2/MITD1 ratio | GCST90315214 | 0.57 |
| 4474 | CAG-776 abundance in stool | GCST90032297 | 0.57 |
| 4475 | CNTNAP2/DPP10 ratio | GCST90314167 | 0.57 |
| 4476 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T387 | ECGA000387 | 0.57 |
| 4477 | Ulcerative colitis (PheCode 555.2) | GCST90044155 | 0.57 |
| 4478 | Asthma | Chronic lower respiratory diseases | UKBB00000053 | 0.56 |
| 4479 | PRR15 levels | GCST90424790 | 0.56 |
| 4480 | X-11786--methylcysteine levels | GCST90243654 | 0.56 |
| 4481 | Right ventricular stroke volume | GCST90268122 | 0.56 |
| 4482 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T4 | ECGA000004 | 0.56 |
| 4483 | FUT8/TNFSF14 ratio | GCST90314895 | 0.56 |
| 4484 | X-04499--3,4-dihydroxybutyrate levels | GCST90243497 | 0.56 |
| 4485 | HippSubfield lh volume CA4-body | GCST90002683 | 0.56 |
| 4486 | Selective deficiency of immunoglobulin G [IgG] subclasses | FING00001288 | 0.56 |
| 4487 | COLEC12/LTBR ratio | GCST90314182 | 0.56 |
| 4488 | Chronic obstructive pulmonary disease x current smoker interaction (main effect) | GCST90016591 | 0.56 |
| 4489 | DNAJB14 levels | GCST90427235 | 0.56 |
| 4490 | SFTPA1 levels | GCST90470612 | 0.56 |
| 4491 | FLT3LG levels | GCST90274791 | 0.56 |
| 4492 | APOA4 levels | GCST90468333 | 0.56 |
| 4493 | ALKBH3 levels | GCST90619095 | 0.56 |
| 4494 | CCER2 levels | GCST90468563 | 0.56 |
| 4495 | MVK levels | GCST90469967 | 0.56 |
| 4496 | CPB1 levels | GCST90468839 | 0.56 |
| 4497 | Headaches for 3+ months | Pain | UKBB00000307 | 0.56 |
| 4498 | Retention of urine (PheCode 599.2) | GCST90476150 | 0.56 |
| 4499 | Non-seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00000874 | 0.56 |
| 4500 | C7 levels | GCST90468502 | 0.56 |
| 4501 | PTPRN2 levels | GCST90470385 | 0.55 |
| 4502 | EDAR/F11R ratio | GCST90314576 | 0.55 |
| 4503 | CD300LG/DSG2 ratio | GCST90313802 | 0.55 |
| 4504 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T367 | ECGA000367 | 0.55 |
| 4505 | Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers) | FING00000771 | 0.55 |
| 4506 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 92) | GCST90320911 | 0.55 |
| 4507 | Atrial fibrillation/atrial flutter | GCST90018576 | 0.55 |
| 4508 | Acute peritonitis | FING00000028 | 0.55 |
| 4509 | LEFTY2 levels | GCST90469752 | 0.55 |
| 4510 | Type 2 diabetes (PheCode 250.2) | GCST90475667 | 0.55 |
| 4511 | MRPL33 levels | GCST90617986 | 0.55 |
| 4512 | Other eye problems | Eyesight | UKBB00000610 | 0.55 |
| 4513 | F-chocolate/coffee liking (derived food-liking factor) | GCST90094735 | 0.55 |
| 4514 | Active to sedentary transition probability | GCST90061429 | 0.55 |
| 4515 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T386 | ECGA000386 | 0.55 |
| 4516 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T163 | ECGU000163 | 0.55 |
| 4517 | EGFLAM levels | GCST90469084 | 0.55 |
| 4518 | Left-hemisphere default mode network to right-hemisphere dorsal attention network white-matter structural connectivity | GCST90302762 | 0.55 |
| 4519 | PER3 levels | GCST90470210 | 0.55 |
| 4520 | VAV3 levels | GCST90471030 | 0.55 |
| 4521 | CNTN3/NCS1 ratio | GCST90314165 | 0.55 |
| 4522 | PPM1F levels | GCST90470297 | 0.55 |
| 4523 | Chronic obstructive pulmonary disease in non-current smokers | GCST90016594 | 0.55 |
| 4524 | F10 levels | GCST90469163 | 0.54 |
| 4525 | Phospholipids in large HDL (UKB data field 23560) | GCST90269657 | 0.54 |
| 4526 | Types of transport used (excluding work) - Walk | Physical activity | UKBB00000879 | 0.54 |
| 4527 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T421 | ECGU000421 | 0.54 |
| 4528 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T390 | ECGA000390 | 0.54 |
| 4529 | CSNK1D levels | GCST90468888 | 0.54 |
| 4530 | IPCEF1/TBCB ratio | GCST90315187 | 0.54 |
| 4531 | Volume of left basal nucleus | GCST90474877 | 0.54 |
| 4532 | Volume of left lateral nucleus | GCST90474970 | 0.54 |
| 4533 | GC levels | GCST90162564 | 0.54 |
| 4534 | AHCY/FABP5 ratio | GCST90313208 | 0.54 |
| 4535 | EDAR/ERBIN ratio | GCST90314575 | 0.54 |
| 4536 | IDP dMRI ProbtrackX L2 cgc l | GCST90004277 | 0.53 |
| 4537 | SIRT1 levels | GCST90470641 | 0.53 |
| 4538 | RUVBL1 levels | GCST90470509 | 0.53 |
| 4539 | MCAM/NCAM1 ratio | GCST90315408 | 0.53 |
| 4540 | Acute pancreatitis | GCST90018569 | 0.53 |
| 4541 | CX3CL1 levels | GCST90468921 | 0.53 |
| 4542 | COMP/THBS4 ratio | GCST90314193 | 0.53 |
| 4543 | CHI3L1/HSPG2 ratio | GCST90314043 | 0.53 |
| 4544 | ROBO1/SPON1 ratio | GCST90315783 | 0.53 |
| 4545 | Pain type(s) experienced in last month - Headache | Pain | UKBB00000627 | 0.53 |
| 4546 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T468 | ECGU000468 | 0.53 |
| 4547 | Hippocampal subfield left CA3 volume (body) | GCST90267940 | 0.53 |
| 4548 | Left ventricular end diastole anterospetal wall thickness | GCST90278519 | 0.53 |
| 4549 | LY75 levels | GCST90469822 | 0.53 |
| 4550 | Tea without sugar liking | GCST90094858 | 0.53 |
| 4551 | EDAR/LAT2 ratio | GCST90314582 | 0.53 |
| 4552 | HPGDS levels | GCST90469472 | 0.53 |
| 4553 | CST3/TAFA5 ratio | GCST90314298 | 0.53 |
| 4554 | CRNN levels | GCST90277890 | 0.53 |
| 4555 | Urine 5-acetylamino-6-amino-3-methyluracil levels in chronic kidney disease | GCST90264674 | 0.53 |
| 4556 | ENPP6 levels | GCST90469117 | 0.53 |
| 4557 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142 | ECGU000142 | 0.53 |
| 4558 | Aspartate aminotransferase levels | GCST90278618 | 0.53 |
| 4559 | rfMRI connectivity ICA-features 6 | GCST90006344 | 0.53 |
| 4560 | aparc-a2009s lh area S-oc-middle+Lunatus | GCST90003353 | 0.53 |
| 4561 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115 | ECGU000115 | 0.53 |
| 4562 | IL1R2/MEGF9 ratio | GCST90315159 | 0.53 |
| 4563 | TMSB10 levels | GCST90470894 | 0.53 |
| 4564 | CPA1 levels | GCST90468836 | 0.52 |
| 4565 | Total cholesterol response to statins (relative logarithmic difference) | GCST90455608 | 0.52 |
| 4566 | EDAR/PRDX5 ratio | GCST90314583 | 0.52 |
| 4567 | IDP dMRI ProbtrackX L1 cgh l | GCST90004252 | 0.52 |
| 4568 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T165 | ECGU000165 | 0.52 |
| 4569 | X-12216 levels | GCST90200483 | 0.52 |
| 4570 | Ovarian cyst | FING00001132 | 0.52 |
| 4571 | All anxiety disorders | FING00000059 | 0.52 |
| 4572 | Snoring | GCST009761 | 0.52 |
| 4573 | Triacylglycerol_51:4_[M+NH4]1+ levels | GCST90060491 | 0.52 |
| 4574 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320928 | 0.52 |
| 4575 | ARHGAP45 levels | GCST90468355 | 0.52 |
| 4576 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T134 | ECGU000134 | 0.52 |
| 4577 | CLUL1 levels | GCST90468792 | 0.52 |
| 4578 | Medication for pain relief, constipation, heartburn - Aspirin | Medication | UKBB00000454 | 0.52 |
| 4579 | Bioavailable testosterone levels | GCST90012104 | 0.52 |
| 4580 | Docosahexaenoic acid to total fatty acids percentage | GCST90502285 | 0.52 |
| 4581 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T391 | ECGA000391 | 0.52 |
| 4582 | PCBP2 levels | GCST90470167 | 0.52 |
| 4583 | aparc-a2009s lh volume G-front-inf-Triangul | GCST90002938 | 0.52 |
| 4584 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T369 | ECGA000369 | 0.51 |
| 4585 | ICD10 O00: Ectopic pregnancy | GCST90454227 | 0.51 |
| 4586 | Ectopic pregnancy | GCST90272883 | 0.51 |
| 4587 | wg rh intensity-contrast superiorparietal | GCST90003855 | 0.51 |
| 4588 | CD55 levels | GCST90468637 | 0.51 |
| 4589 | SSH3 levels | GCST90470749 | 0.51 |
| 4590 | Acne (PheCode 706.1) | GCST90476211 | 0.51 |
| 4591 | Heart failure, strict | FING00000606 | 0.51 |
| 4592 | Left-hemisphere salience/ventral attention network to left-hemisphere control network white-matter structural connectivity | GCST90302710 | 0.51 |
| 4593 | SLC51B levels | GCST90470664 | 0.51 |
| 4594 | VWA1 levels | GCST90471061 | 0.51 |
| 4595 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T57 | ECGU000057 | 0.51 |
| 4596 | triglyceride (minimum, inv-norm transformed) | GCST90476437 | 0.51 |
| 4597 | CCL13/CCL17 ratio | GCST90313674 | 0.51 |
| 4598 | Moderate to vigorous physical activity levels | GCST006097 | 0.51 |
| 4599 | SRP14 levels | GCST90470742 | 0.51 |
| 4600 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T64 | ECGA000064 | 0.51 |
| 4601 | wg lh intensity-contrast posteriorcingulate | GCST90003814 | 0.51 |
| 4602 | SNAP23/TXLNA ratio | GCST90315857 | 0.51 |
| 4603 | CST3/TIMP1 ratio | GCST90314300 | 0.51 |
| 4604 | FLT4/KDR ratio | GCST90314861 | 0.51 |
| 4605 | IDP dMRI TBSS ICVF Superior corona radiata L | GCST90004352 | 0.51 |
| 4606 | Eczema | GCST90468126 | 0.51 |
| 4607 | UBXN1 levels | GCST90471004 | 0.51 |
| 4608 | ICA1 levels | GCST90469497 | 0.50 |
| 4609 | Pork consumption | GCST90132999 | 0.50 |
| 4610 | TACSTD2 levels | GCST90470798 | 0.50 |
| 4611 | CDKN2D/MANF ratio | GCST90313989 | 0.50 |
| 4612 | REST UKBBICA NODEamps25 0021 | GCST90385504 | 0.50 |
| 4613 | CRELD2/HYOU1 ratio | GCST90314255 | 0.50 |
| 4614 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T373 | ECGA000373 | 0.50 |
| 4615 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T145 | ECGU000145 | 0.50 |
| 4616 | BCAT1 levels | GCST90468427 | 0.50 |
| 4617 | Other venous embolism and thrombosis (PheCode 452) | GCST90476007 | 0.50 |
| 4618 | CD63/EDAR ratio | GCST90313864 | 0.50 |
| 4619 | PBLD levels | GCST90470163 | 0.50 |
| 4620 | Freckles | GCST006091 | 0.50 |
| 4621 | AGRP levels | GCST90012063 | 0.50 |
| 4622 | Glycosyl ceramide (d18:1/20:0, d16:1/22:0) levels | GCST90200145 | 0.50 |
| 4623 | HEXIM1/IKBKG ratio | GCST90315045 | 0.50 |
| 4624 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T25 | ECGA000025 | 0.50 |
| 4625 | KIAA0319 levels | GCST90469676 | 0.50 |
| 4626 | MIF/SUSD2 ratio | GCST90315452 | 0.50 |
| 4627 | IDP dMRI TBSS L2 Anterior limb of internal capsule L | GCST90004140 | 0.50 |
| 4628 | Temporomandibular joint disorders, including avohilmo | FING00001355 | 0.50 |
| 4629 | FKBP14 levels | GCST90469241 | 0.50 |
| 4630 | MCFD2 levels | GCST90469873 | 0.50 |
| 4631 | AGT levels | GCST90468257 | 0.50 |
| 4632 | PHACTR2 levels | GCST90470224 | 0.50 |
| 4633 | MMP1/MMP3 ratio | GCST90315461 | 0.50 |
| 4634 | Blood cell traits latent factor 14 (red cell) | GCST90559256 | 0.50 |
| 4635 | Tonsillectomy and adenotomy | FING00001367 | 0.50 |
| 4636 | Left-hemisphere control network to left-hemisphere control network white-matter structural connectivity | GCST90302743 | 0.49 |
| 4637 | IDP dMRI TBSS ICVF Anterior limb of internal capsule R | GCST90004343 | 0.49 |
| 4638 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T220 | ECGA000220 | 0.49 |
| 4639 | Other disorders of intestine | digestive | UKBB00000608 | 0.49 |
| 4640 | DCBLD2/PLA2G15 ratio | GCST90314428 | 0.49 |
| 4641 | GP1BA levels | GCST90469380 | 0.49 |
| 4642 | Prescriptions - albuterol | beta2-agonist,bronchodilator,asthma | UKBB00000658 | 0.49 |
| 4643 | Prescriptions - beta2-agonist|bronchodilator|asthma | UKBB00000670 | 0.49 |
| 4644 | ALPP/LAMP3 ratio | GCST90313249 | 0.49 |
| 4645 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T368 | ECGA000368 | 0.49 |
| 4646 | Enteropathic arthropathies | FING00000508 | 0.49 |
| 4647 | ALCAM/IL1RL2 ratio | GCST90313238 | 0.49 |
| 4648 | CAG-776 sp000438195 abundance in stool | GCST90032296 | 0.49 |
| 4649 | WASF1 levels | GCST90471067 | 0.49 |
| 4650 | PLXNA4/VASH1 ratio | GCST90315691 | 0.49 |
| 4651 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T460 | ECGA000460 | 0.49 |
| 4652 | LMOD1 levels | GCST90469783 | 0.49 |
| 4653 | IGFBP6/PTGDS ratio | GCST90315137 | 0.48 |
| 4654 | TDRKH/TST ratio | GCST90315913 | 0.48 |
| 4655 | Hypotaurine levels | GCST90200379 | 0.48 |
| 4656 | CCL21 levels | GCST90468573 | 0.48 |
| 4657 | HEXIM1/NT5C3A ratio | GCST90315048 | 0.48 |
| 4658 | aparc-pial rh area lateraloccipital | GCST90003184 | 0.48 |
| 4659 | ICAM2 levels | GCST90469499 | 0.48 |
| 4660 | PCDH17/THBD ratio | GCST90315607 | 0.48 |
| 4661 | HippSubfield rh volume GC-ML-DG-body | GCST90002703 | 0.48 |
| 4662 | Dizziness and giddiness (Light-headedness and vertigo) (PheCode 386.9) | GCST90475908 | 0.48 |
| 4663 | DPP6/NRCAM ratio | GCST90314542 | 0.48 |
| 4664 | ANXA3/BID ratio | GCST90313279 | 0.48 |
| 4665 | T1 FreeSurfer a2009s rh G cuneus area | GCST90384900 | 0.48 |
| 4666 | BCAM/CDH5 ratio | GCST90313469 | 0.48 |
| 4667 | ANXA10 levels | GCST90468314 | 0.48 |
| 4668 | CC2D1A levels | GCST90468557 | 0.48 |
| 4669 | TGFBR2 levels | GCST90470847 | 0.48 |
| 4670 | Anaphylactic shock due to adverse effect of correct drug or medication properly administered | FING00000084 | 0.48 |
| 4671 | RAB11FIP3 levels | GCST90470404 | 0.48 |
| 4672 | Haemoglobin concentration | Blood count | UKBB00000293 | 0.48 |
| 4673 | Left-hemisphere salience/ventral attention network to right-hemisphere default mode network white-matter structural connectivity | GCST90302718 | 0.48 |
| 4674 | PPL levels | GCST90470294 | 0.48 |
| 4675 | Major depressive disorder (probable) | GCST005904 | 0.48 |
| 4676 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T422 | ECGU000422 | 0.48 |
| 4677 | rfMRI connectivity (ICA100 edge 619) | GCST90005472 | 0.48 |
| 4678 | Multiple system atrophy | GCST90406925 | 0.48 |
| 4679 | FLT1/VEGFA ratio | GCST90314858 | 0.48 |
| 4680 | Left ventricular end diastolic volume (indexed to body surface area) | GCST90435258 | 0.48 |
| 4681 | TNFSF10 levels | GCST90274843 | 0.48 |
| 4682 | CIAPIN1/SNX9 ratio | GCST90314068 | 0.47 |
| 4683 | VEGFC/ZBTB16 ratio | GCST90315946 | 0.47 |
| 4684 | aparc-DKTatlas rh volume parstriangularis | GCST90002911 | 0.47 |
| 4685 | FAM13A levels | GCST90469181 | 0.47 |
| 4686 | Operative procedures - Injection of therapeutic substance into joint | Summary Operations | UKBB00000582 | 0.47 |
| 4687 | Hearing difficulty/problems | Hearing | UKBB00000310 | 0.47 |
| 4688 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320608 | 0.47 |
| 4689 | Breast cancer | GCST004988 | 0.47 |
| 4690 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle R | GCST90004337 | 0.47 |
| 4691 | Episcleritis | FING00000513 | 0.47 |
| 4692 | IDP dMRI TBSS ICVF Fornix cres+Stria terminalis R | GCST90004365 | 0.47 |
| 4693 | CDH5/PCDH17 ratio | GCST90313958 | 0.47 |
| 4694 | HippSubfield rh volume subiculum-body | GCST90002691 | 0.47 |
| 4695 | Succinoyltaurine levels | GCST90200235 | 0.47 |
| 4696 | Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary Operations | UKBB00000575 | 0.47 |
| 4697 | Osteoarthrosis NOS (PheCode 740.9) | GCST90476256 | 0.47 |
| 4698 | Treatment or medication use - rosuvastatin (UKB data field 20003_1141192410) | GCST90042539 | 0.47 |
| 4699 | 1-arachidonoylglycerophosphocholine levels | GCST90243674 | 0.47 |
| 4700 | WFDC1 levels | GCST90471074 | 0.47 |
| 4701 | aseg lh intensity Putamen | GCST90003770 | 0.47 |
| 4702 | Breast cancer | GCST010098 | 0.47 |
| 4703 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T372 | ECGA000372 | 0.47 |
| 4704 | PTPN6/SNAP23 ratio | GCST90315747 | 0.47 |
| 4705 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T388 | ECGA000388 | 0.47 |
| 4706 | IDP dMRI ProbtrackX ICVF str l | GCST90004398 | 0.47 |
| 4707 | Hearing difficulty/problems | Hearing | UKBB00000311 | 0.47 |
| 4708 | Total lipids in HDL (UKB data field 23426) | GCST90269523 | 0.47 |
| 4709 | HEXIM1/NUB1 ratio | GCST90315049 | 0.47 |
| 4710 | CCL5/CXCL3 ratio | GCST90313700 | 0.47 |
| 4711 | total creatine kinase (mean, inv-norm transformed) | GCST90476413 | 0.47 |
| 4712 | Creatinine levels | GCST90278624 | 0.46 |
| 4713 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T389 | ECGA000389 | 0.46 |
| 4714 | PLXNB2 levels | GCST90242299 | 0.46 |
| 4715 | GBA1 levels | GCST90423262 | 0.46 |
| 4716 | CTSO/IGF2R ratio | GCST90314317 | 0.46 |
| 4717 | Free androgen index | GCST90239823 | 0.46 |
| 4718 | EIF4G1 levels | GCST90469097 | 0.46 |
| 4719 | Disorders of eyelid, lacrimal system and orbit | FING00000439 | 0.46 |
| 4720 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T371 | ECGA000371 | 0.46 |
| 4721 | Diacylglycerol (18:0_18:1) levels | GCST90024714 | 0.46 |
| 4722 | SERPINI2 levels | GCST90470603 | 0.46 |
| 4723 | AP3B1 levels | GCST90468325 | 0.46 |
| 4724 | IDP T1 FAST ROIs R cerebellum V | GCST90002565 | 0.46 |
| 4725 | BA-exvivo rh area BA6 | GCST90003227 | 0.46 |
| 4726 | Plasma N-acetylhistidine levels in chronic kidney disease | GCST90265576 | 0.46 |
| 4727 | DTI autoptx MD atr r tract | GCST90385223 | 0.46 |
| 4728 | LCN15 levels | GCST90469746 | 0.46 |
| 4729 | aseg global volume BrainSegNotVentSurf | GCST90002592 | 0.46 |
| 4730 | CACNB3 levels | GCST90468523 | 0.46 |
| 4731 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T366 | ECGA000366 | 0.46 |
| 4732 | NT5C3A levels | GCST90470091 | 0.46 |
| 4733 | ICD10 N83.0, N83.1, N83.2: Ovarian cyst, including follicular cyst, corpus luteum cyst, and other/unspecified ovarian cyst | GCST90454215 | 0.46 |
| 4734 | GLOD4 levels | GCST90469359 | 0.46 |
| 4735 | Sleep apnoea, including avohilmo | FING00001310 | 0.46 |
| 4736 | POSTN levels | GCST90470288 | 0.46 |
| 4737 | Mean volume of bilateral amygdala | GCST90474992 | 0.46 |
| 4738 | IDP dMRI ProbtrackX ICVF atr l | GCST90004377 | 0.45 |
| 4739 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T160 | ECGU000160 | 0.45 |
| 4740 | APOE levels | GCST90468338 | 0.45 |
| 4741 | IDP T1 FAST ROIs R subcallosal cortex | GCST90002504 | 0.45 |
| 4742 | NUMB levels | GCST90470108 | 0.45 |
| 4743 | ADD1 levels | GCST90468233 | 0.45 |
| 4744 | GPC1 levels | GCST90469386 | 0.45 |
| 4745 | IDP SWI T2star left caudate | GCST90003865 | 0.45 |
| 4746 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T370 | ECGA000370 | 0.45 |
| 4747 | Gestational [pregnancy-induced] oedema and proteinuria without hypertension | FING00000572 | 0.45 |
| 4748 | ANGPT1/MPIG6B ratio | GCST90313265 | 0.45 |
| 4749 | CHGA levels | GCST90240699 | 0.45 |
| 4750 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T46 | ECGA000046 | 0.45 |
| 4751 | Chronic obstructive pulmonary disease x ever smoker interaction (main effect) | GCST90016586 | 0.45 |
| 4752 | Otosclerosis | GCST90129575 | 0.45 |
| 4753 | PEAR1/SCARF1 ratio | GCST90315642 | 0.45 |
| 4754 | Blood cell traits latent factor 13 (red cell) | GCST90559255 | 0.45 |
| 4755 | Cancer code, self-reported: breast cancer (UKB data field 20001_1002) | GCST90041886 | 0.45 |
| 4756 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T113 | ECGU000113 | 0.45 |
| 4757 | PRTFDC1 levels | GCST90470346 | 0.45 |
| 4758 | NAGPA levels | GCST90242004 | 0.45 |
| 4759 | ZBTB17 levels | GCST90471096 | 0.45 |
| 4760 | CEACAM8/RNASE3 ratio | GCST90314004 | 0.45 |
| 4761 | BTN2A1/SMOC2 ratio | GCST90313549 | 0.45 |
| 4762 | Heart rate variability traits (RMSSD) | GCST004733 | 0.45 |
| 4763 | GIT1 levels | GCST90469351 | 0.45 |
| 4764 | Asthma | GCST90014325 | 0.45 |
| 4765 | Medication for pain relief, constipation, heartburn - Ibuprofen (e.g. Nurofen) | Medication | UKBB00000455 | 0.45 |
| 4766 | IDP dMRI TBSS FA Superior cerebellar peduncle L | GCST90003890 | 0.44 |
| 4767 | Urinary calculus | genitourinary | UKBB00000886 | 0.44 |
| 4768 | Cardiac pacemaker in situ (PheCode 426.91) | GCST90475960 | 0.44 |
| 4769 | Estimated glomerular filtration rate (creatinine) | GCST90103634 | 0.44 |
| 4770 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007528 | 0.44 |
| 4771 | MAPKAPK2 levels | GCST90469858 | 0.44 |
| 4772 | EDAR/SPARC ratio | GCST90314588 | 0.44 |
| 4773 | Disorders of vestibular function (Vertigo) | FING00000464 | 0.44 |
| 4774 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T374 | ECGA000374 | 0.44 |
| 4775 | Urate levels (UKB data field 30880) | GCST90468107 | 0.44 |
| 4776 | PLEKHO1 levels | GCST90470256 | 0.44 |
| 4777 | TMED8 levels | GCST90470885 | 0.44 |
| 4778 | MYOM3 levels | GCST90469986 | 0.44 |
| 4779 | Docosahexaenoic acid levels | GCST90502259 | 0.44 |
| 4780 | Paternal history of Alzheimer's disease | GCST005920 | 0.44 |
| 4781 | IDP dMRI TBSS ICVF Anterior corona radiata R | GCST90004349 | 0.44 |
| 4782 | ICOSLG levels | GCST90469503 | 0.44 |
| 4783 | aparc-pial rh area caudalmiddlefrontal | GCST90003177 | 0.44 |
| 4784 | P4HB levels | GCST90470140 | 0.44 |
| 4785 | Ceramide (d18:2/22:0) levels | GCST90024054 | 0.44 |
| 4786 | Phospholipids in HDL (UKB data field 23414) | GCST90269511 | 0.44 |
| 4787 | NUDC levels | GCST90470102 | 0.44 |
| 4788 | CCL25 levels | GCST90274768 | 0.44 |
| 4789 | Takes medication for skin cancer? | GCST90475190 | 0.44 |
| 4790 | GAL levels | GCST90469300 | 0.44 |
| 4791 | Benign mammary dysplasia | FING00000151 | 0.43 |
| 4792 | IDP dMRI TBSS L1 Sagittal stratum R | GCST90004105 | 0.43 |
| 4793 | Other anxiety disorders | FING00000960 | 0.43 |
| 4794 | KLK4 levels | GCST90469704 | 0.43 |
| 4795 | Treatment/medication code - perindopril | Medications | UKBB00000854 | 0.43 |
| 4796 | FOXO3/SH2B3 ratio | GCST90314881 | 0.43 |
| 4797 | SERPINB9 levels | GCST90470593 | 0.43 |
| 4798 | ITGB5 levels | GCST90469645 | 0.43 |
| 4799 | Calculus of kidney | genitourinary | UKBB00000115 | 0.43 |
| 4800 | DTI TBSS L2 Sagittal stratum R | GCST90384506 | 0.43 |
| 4801 | Lysoalkylphosphatidylcholine (O-20:0) levels | GCST90025432 | 0.43 |
| 4802 | aparc-pial rh area inferiorparietal | GCST90003181 | 0.43 |
| 4803 | NIT1 levels | GCST90470050 | 0.43 |
| 4804 | Left-hemisphere dorsal attention network to right-hemisphere limbic network white-matter structural connectivity | GCST90302698 | 0.43 |
| 4805 | estimated glomerular filtration rate (eGFR, maximum, inv-norm transformed) | GCST90475280 | 0.43 |
| 4806 | aparc-pial lh area TotalSurface | GCST90003141 | 0.42 |
| 4807 | LHPP levels | GCST90469768 | 0.42 |
| 4808 | TAB2 levels | GCST90470796 | 0.42 |
| 4809 | Excessive scarring | GCST90483368 | 0.42 |
| 4810 | SERPINA3 levels | GCST90470583 | 0.42 |
| 4811 | SMAD3 levels | GCST90470677 | 0.42 |
| 4812 | BSG/CKAP4 ratio | GCST90313531 | 0.42 |
| 4813 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T375 | ECGA000375 | 0.42 |
| 4814 | HDL cholesterol levels (UKB data field 30760) | GCST90468075 | 0.42 |
| 4815 | SIRT2 levels | GCST90470642 | 0.42 |
| 4816 | Allergic rhinitis | GCST90086042 | 0.42 |
| 4817 | PEAR1/SPINT2 ratio | GCST90315644 | 0.42 |
| 4818 | CCN3 levels | GCST90242492 | 0.42 |
| 4819 | PMVK levels | GCST90470272 | 0.42 |
| 4820 | Hemoglobin concentration | GCST90002310 | 0.42 |
| 4821 | MSR1/TNFRSF21 ratio | GCST90315494 | 0.42 |
| 4822 | Weight (minimum, inv-normal transformed) | GCST90476466 | 0.42 |
| 4823 | CST6/NECTIN4 ratio | GCST90314303 | 0.42 |
| 4824 | SLMAP levels | GCST90470673 | 0.42 |
| 4825 | Neonatal jaundice (paternal effect) | GCST90435147 | 0.42 |
| 4826 | Nonalcoholic fatty liver disease | GCST90054782 | 0.42 |
| 4827 | Blood cell traits latent factor 5 (platelet) | GCST90559247 | 0.42 |
| 4828 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T162 | ECGU000162 | 0.42 |
| 4829 | Lysophosphatidylcholine (26:0) [sn1] levels | GCST90024188 | 0.42 |
| 4830 | aparc-pial lh area parstriangularis | GCST90003160 | 0.42 |
| 4831 | MMP8 levels | GCST90469922 | 0.42 |
| 4832 | SCARF1/TNFRSF14 ratio | GCST90315812 | 0.42 |
| 4833 | GP1BB levels | GCST90469381 | 0.42 |
| 4834 | Hematocrit | GCST90002304 | 0.42 |
| 4835 | Hematocrit | GCST004604 | 0.42 |
| 4836 | Phlebitis and thrombophlebitis (PheCode 451) | GCST90476003 | 0.42 |
| 4837 | Other diseases of the digestive system | FING00001010 | 0.41 |
| 4838 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T229 | ECGU000229 | 0.41 |
| 4839 | Spread type: Any oil based spread vs never use spread (UKB data field 1428) | GCST90132949 | 0.41 |
| 4840 | Diabetes mellitus (PheCode 250) | GCST90475658 | 0.41 |
| 4841 | FOLH1 levels | GCST90469258 | 0.41 |
| 4842 | Other disorders of circulatory system | circulatory system | UKBB00000607 | 0.41 |
| 4843 | aparc-Desikan rh area precentral | GCST90003130 | 0.41 |
| 4844 | Red meat liking | GCST90094819 | 0.41 |
| 4845 | IDP dMRI TBSS FA Posterior thalamic radiation L | GCST90003906 | 0.41 |
| 4846 | CAG-273 sp003507395 abundance in stool | GCST90032269 | 0.41 |
| 4847 | GM2A levels | GCST90469365 | 0.41 |
| 4848 | 1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels | GCST90200692 | 0.41 |
| 4849 | VTI1A levels | GCST90471060 | 0.41 |
| 4850 | Facial pigmentation measurement (polar light) | GCST90002284 | 0.41 |
| 4851 | Retinal thickness (functional principal component 5) | GCST90455725 | 0.41 |
| 4852 | Volume of right basal nucleus | GCST90474910 | 0.41 |
| 4853 | CHL1 levels | GCST90468745 | 0.41 |
| 4854 | DOK2/LACTB2 ratio | GCST90314532 | 0.41 |
| 4855 | Platelet count during third trimester of pregnancy | GCST90302226 | 0.41 |
| 4856 | Docosahexaenoic acid to total fatty acids percentage | GCST90501991 | 0.41 |
| 4857 | CD69/TXNDC5 ratio | GCST90313889 | 0.41 |
| 4858 | Fracture of radius and ulna (PheCode 803.2) | GCST90476280 | 0.41 |
| 4859 | PRAP1 levels | GCST90470312 | 0.41 |
| 4860 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T439 | ECGU000439 | 0.41 |
| 4861 | CXCL11 levels | GCST90274781 | 0.41 |
| 4862 | PDAP1 levels | GCST90470179 | 0.41 |
| 4863 | CHRDL1/SMOC2 ratio | GCST90314062 | 0.41 |
| 4864 | VPS4B levels | GCST90471047 | 0.41 |
| 4865 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 65) | GCST90320884 | 0.41 |
| 4866 | HEXIM1 levels | GCST90469447 | 0.41 |
| 4867 | N-formylanthranilic acid levels | GCST90199960 | 0.41 |
| 4868 | GLA levels | GCST90469354 | 0.41 |
| 4869 | Seminoma of testis, excluding all cancers (controls excluding all cancers) | FING00001289 | 0.41 |
| 4870 | Type 1 diabetes | GCST90000529 | 0.41 |
| 4871 | PCDH1 levels | GCST90470170 | 0.41 |
| 4872 | BMP6/SPINT2 ratio | GCST90313529 | 0.41 |
| 4873 | IDP T1 FAST ROIs V cerebellum crus II | GCST90002573 | 0.40 |
| 4874 | Left-hemisphere control network to hippocampus white-matter structural connectivity | GCST90302756 | 0.40 |
| 4875 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T109 | ECGU000109 | 0.40 |
| 4876 | PLXNB3 levels | GCST90470267 | 0.40 |
| 4877 | VSIG10 levels | GCST90471050 | 0.40 |
| 4878 | GRN levels | GCST90469404 | 0.40 |
| 4879 | DKK1/MGLL ratio | GCST90314473 | 0.40 |
| 4880 | Deep vein thrombosis [DVT] (PheCode 452.2) | GCST90476010 | 0.40 |
| 4881 | KYNU levels | GCST90469722 | 0.40 |
| 4882 | MESD/NCK2 ratio | GCST90315421 | 0.40 |
| 4883 | aparc-a2009s rh volume S-collat-transv-ant | GCST90003048 | 0.40 |
| 4884 | DTI TBSS L2 Anterior limb of internal capsule R | GCST90384492 | 0.40 |
| 4885 | DOK1 levels | GCST90469028 | 0.40 |
| 4886 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T24 | ECGA000024 | 0.40 |
| 4887 | SERPINA12 levels | GCST90470581 | 0.40 |
| 4888 | Frequency of tenseness / restlessness in last 2 weeks | Mental health | UKBB00000267 | 0.40 |
| 4889 | MPI/TACC3 ratio | GCST90315491 | 0.40 |
| 4890 | CD40/TIMP3 ratio | GCST90313829 | 0.40 |
| 4891 | PCSK9 levels | GCST90470177 | 0.40 |
| 4892 | GP2 levels | GCST90469382 | 0.40 |
| 4893 | Pneumonia | GCST90018681 | 0.40 |
| 4894 | BA-exvivo lh thickness MT | GCST90003524 | 0.40 |
| 4895 | CD209/ITGAV ratio | GCST90313753 | 0.40 |
| 4896 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T443 | ECGU000443 | 0.40 |
| 4897 | Medication for pain relief, constipation, heartburn - Paracetamol | Medication | UKBB00000459 | 0.40 |
| 4898 | MINK1 levels | GCST90469909 | 0.40 |
| 4899 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T376 | ECGA000376 | 0.39 |
| 4900 | Trunk fat mass | Impedance measures | UKBB00000863 | 0.39 |
| 4901 | Childhood sunburn occasions | Sun exposure | UKBB00000130 | 0.39 |
| 4902 | Methods of admission to hospital (recoded) - Elective admission: Planned | Summary Administration | UKBB00000462 | 0.39 |
| 4903 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502570 | 0.39 |
| 4904 | PPP3R1 levels | GCST90470307 | 0.39 |
| 4905 | DTNB levels | GCST90469046 | 0.39 |
| 4906 | IDP T1 FAST ROIs L cerebellum crus I | GCST90002569 | 0.39 |
| 4907 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T378 | ECGA000378 | 0.39 |
| 4908 | Total Phosphatidylethanolamine levels | GCST90025207 | 0.39 |
| 4909 | UNC5D levels | GCST90471010 | 0.39 |
| 4910 | Acute osteomyelitis (PheCode 710.11) | GCST90476222 | 0.39 |
| 4911 | GLT25D1 levels | GCST90426421 | 0.39 |
| 4912 | Chronic airway obstruction | respiratory | UKBB00000135 | 0.39 |
| 4913 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T10 | ECGA000010 | 0.39 |
| 4914 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T385 | ECGA000385 | 0.39 |
| 4915 | Breast cancer (estrogen-receptor negative) | GCST005076 | 0.39 |
| 4916 | Loneliness (weighted GWA) | GCST90267289 | 0.39 |
| 4917 | CALCOCO1 levels | GCST90468530 | 0.39 |
| 4918 | IDP dMRI TBSS ICVF Anterior corona radiata L | GCST90004350 | 0.39 |
| 4919 | F9 levels | GCST90469172 | 0.39 |
| 4920 | Chronic obstructive pulmonary disease in never smokers | GCST90016589 | 0.39 |
| 4921 | CLEC1B/NSFL1C ratio | GCST90314099 | 0.39 |
| 4922 | PDGFRA levels | GCST90421093 | 0.39 |
| 4923 | IDP dMRI TBSS ICVF Sagittal stratum R | GCST90004357 | 0.39 |
| 4924 | Hematocrit | GCST90002383 | 0.39 |
| 4925 | CRKL/MGLL ratio | GCST90314270 | 0.39 |
| 4926 | aparc-a2009s rh area G+S-occipital-inf | GCST90003372 | 0.38 |
| 4927 | SMTN levels | GCST90470689 | 0.38 |
| 4928 | 4-acetamidobutanoate levels | GCST90243440 | 0.38 |
| 4929 | SPART levels | GCST90470719 | 0.38 |
| 4930 | Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000167 | 0.38 |
| 4931 | Gastric cancer | GCST90018629 | 0.38 |
| 4932 | HippSubfield lh volume Hippocampal-tail | GCST90002668 | 0.38 |
| 4933 | DTI TBSS MD Posterior corona radiata R | GCST90384598 | 0.38 |
| 4934 | wg lh intensity-contrast inferiorparietal | GCST90003799 | 0.38 |
| 4935 | T1 FreeSurfer aseg Left-Putamen | GCST90384145 | 0.38 |
| 4936 | ATF6 levels | GCST90240816 | 0.38 |
| 4937 | rfMRI connectivity (ICA100 edge 614) | GCST90005467 | 0.38 |
| 4938 | Arthropathies | FING00000107 | 0.38 |
| 4939 | HSPB1 levels | GCST90469489 | 0.38 |
| 4940 | Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302748 | 0.38 |
| 4941 | XIAP levels | GCST90471083 | 0.38 |
| 4942 | High density lipoprotein cholesterol levels | GCST90239651 | 0.38 |
| 4943 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T228 | ECGA000228 | 0.38 |
| 4944 | MEPE/SOST ratio | GCST90315420 | 0.38 |
| 4945 | Sedentary behavior at work | GCST90104345 | 0.38 |
| 4946 | Cholesteryl ester_16:0_[M+NH4]1+ levels | GCST90060211 | 0.38 |
| 4947 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T437 | ECGU000437 | 0.37 |
| 4948 | GPC1/ITGB6 ratio | GCST90314977 | 0.37 |
| 4949 | PDLIM7/PLA2G4A ratio | GCST90315637 | 0.37 |
| 4950 | Sebaceous cyst (PheCode 706.2) | GCST90476213 | 0.37 |
| 4951 | Omega-3 fatty acids to total fatty acids percentage | GCST90502090 | 0.37 |
| 4952 | Platelet count | GCST90002358 | 0.37 |
| 4953 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T241 | ECGU000241 | 0.37 |
| 4954 | IFNGR2 levels | GCST90469514 | 0.37 |
| 4955 | NFE2 levels | GCST90470035 | 0.37 |
| 4956 | F-healthy breakfast food liking (derived food-liking factor) | GCST90094780 | 0.37 |
| 4957 | aparc-DKTatlas rh area parstriangularis | GCST90003283 | 0.37 |
| 4958 | Retention of urine | FING00001257 | 0.37 |
| 4959 | MARS1 levels | GCST90469862 | 0.37 |
| 4960 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T465 | ECGU000465 | 0.37 |
| 4961 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119) | GCST90320682 | 0.37 |
| 4962 | Myristoyl dihydrosphingomyelin (d18:0/14:0) levels | GCST90200049 | 0.37 |
| 4963 | DNAJA2/PLXNA4 ratio | GCST90314504 | 0.37 |
| 4964 | IDP dMRI ProbtrackX L3 fma | GCST90004310 | 0.37 |
| 4965 | Triacylglycerol_54:7_[M+NH4]1+ levels | GCST90060536 | 0.37 |
| 4966 | Other dorsopathies, not elsewhere classified | FING00001041 | 0.37 |
| 4967 | Thyroid stimulating hormone levels | GCST90319321 | 0.37 |
| 4968 | Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453) | GCST90269550 | 0.37 |
| 4969 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T114 | ECGU000114 | 0.37 |
| 4970 | PAXX levels | GCST90470161 | 0.37 |
| 4971 | IDP dMRI TBSS ICVF Tapetum L | GCST90004374 | 0.37 |
| 4972 | ADGRE5/GAS6 ratio | GCST90313179 | 0.37 |
| 4973 | LGALS8/VWF ratio | GCST90315322 | 0.37 |
| 4974 | ASPSCR1 levels | GCST90468378 | 0.37 |
| 4975 | NID1 levels | GCST90470047 | 0.37 |
| 4976 | CTSH levels | GCST90468913 | 0.37 |
| 4977 | AP1G2 levels | GCST90468323 | 0.36 |
| 4978 | MYOC/NOTCH3 ratio | GCST90315507 | 0.36 |
| 4979 | Isoleucine levels (UKB data field 23465) | GCST90269562 | 0.36 |
| 4980 | ITGB1BP2/MED18 ratio | GCST90315213 | 0.36 |
| 4981 | T1 FreeSurfer DKT lh superiortemporal thickness | GCST90384252 | 0.36 |
| 4982 | LRP11/NECTIN2 ratio | GCST90315329 | 0.36 |
| 4983 | S100A12 levels | GCST90470513 | 0.36 |
| 4984 | Fracture of lumbar spine and pelvis | FING00000556 | 0.36 |
| 4985 | TGOLN2 levels | GCST90470850 | 0.36 |
| 4986 | HS6ST1/MEGF9 ratio | GCST90315081 | 0.36 |
| 4987 | Breast cancer | GCST90468117 | 0.36 |
| 4988 | Medication use (diuretics) | GCST90018765 | 0.36 |
| 4989 | T1 CAT volume L LeftAccumbens | GCST90384108 | 0.36 |
| 4990 | PEBP1 levels | GCST90470205 | 0.36 |
| 4991 | Takes medication for Diabetes/sugar? | GCST90475268 | 0.36 |
| 4992 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T420 | ECGU000420 | 0.36 |
| 4993 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T63 | ECGU000063 | 0.36 |
| 4994 | Volume of right lateral nucleus | GCST90475036 | 0.36 |
| 4995 | aparc-DKTatlas lh area rostralmiddlefrontal | GCST90003259 | 0.36 |
| 4996 | Arthrosis | FING00000111 | 0.36 |
| 4997 | DBNL/PDGFB ratio | GCST90314422 | 0.36 |
| 4998 | Belief that own life is meaningful | Happiness and subjective well-being | UKBB00000090 | 0.36 |
| 4999 | Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632) | GCST90269729 | 0.36 |
| 5000 | CLEC14A/EPHB4 ratio | GCST90314079 | 0.36 |